Work

Real-World Safety Profile of Cenegermin Per FDA Adverse Event Reporting System

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Ocular Pharmacology and Therapeutics

DOI: 10.1089/jop.2025.0023

Authors: Hassaam S. Choudhry, Mingzhuo Pei, David Mothy, Julie Scarfuto, Shahzad I. Mian

Institutions: Rutgers New Jersey Medical School, University of Michigan, Michigan Medicine

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410173399

FWCI: 2.736

Cites: 12

Cited by: 2

Related to: 10